Specifications include, but are not limited to: The vendor shall have the experience, competence, and proficiency to provide postmortem testing for genetic markers for cardiac arrhythmogenic syndromes, analyses, and reporting, as well as serve as an expert witness in legal proceedings. Specifically, these services are to be conducted at the request of and in consultation with Medical Examiners with approval from the Chief Medical Examiner and/or his/her designee(s). 2) The vendor shall have and maintain College of American Pathologists (CAP) accreditation. In addition, the vendor shall have and maintain Clinical Laboratory Improvement Amendments (CLIA) certification. The vendor shall notify JPSC within two (2) business days of any change in the status of its CAP accreditation and CLIA certification. 3) The vendor shall provide detection of genetic cardiac arrhythmogenic syndromes including, but not limited to cardiomyopathy, arrythmias (dilated cardiomyopathy, hypertrophic cardiomyopathy, and left ventricular non-compaction cardiomyopathy, long QT syndrome, short QT syndrome, Brugada syndrome).
